Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07371390 · ClinicalTrials.gov registry record · NA
Minimal Sedation During Knee Replacement Surgery
A NA study of Total Knee Arthroplasty, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07371390: Recruiting NA study of Total Knee Arthroplasty, sponsored by Mayo Clinic.
NCT07371390 is a NA study of Total Knee Arthroplasty that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 200 participants, below the 288-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07371390, a NA study of Total Knee Arthroplasty, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the use of active noise cancelling headphones with music or a movie during knee replacement surgery. Feedback from the surgical team and from patients regarding the headset system will be gathered to see if using it can reduce the amount of sedation needed during knee replacement procedures that use localized anesthesia.
Primary Outcome
Richmond Agitation-Sedation Scale (RASS) measures the amount of sedation necessary for a patient at different levels of discomfort or agitation during local anesthesia surgeries.
Conditions Studied
Interventions
- DEVICE Active Noise Cancelling Headset System
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-12-11 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What NCT07371390 shows while recruiting
NCT07371390 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 288-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Active Noise Cancelling Headset System is the first listed.
NCT07371390 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07371390 about?
NCT07371390 is a clinical study titled "Minimal Sedation During Knee Replacement Surgery". This study will test the use of active noise cancelling headphones with music or a movie during knee replacement surgery. Feedback from the surgical team and from patients regarding the headset system will be gathered to see if using it can reduce the amount of sedation needed during knee replacemen...
What is the current status of trial NCT07371390?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-12-11. Estimated completion is 2027-05-01.
What conditions does trial NCT07371390 study?
This clinical trial studies the following conditions: Total Knee Arthroplasty.
What interventions are being tested in trial NCT07371390?
The interventions under investigation include: Active Noise Cancelling Headset System (DEVICE).
Who is sponsoring clinical trial NCT07371390?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07371390 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07371390's enrollment target sits among peer trials
200 6th of 29 higher than 22 of 29 other Total Knee Arthroplasty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraoperative VR for Older Patients Undergoing TKA
RECRUITING · NA
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
RECRUITING · NA
-
Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery
RECRUITING · NA
-
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
RECRUITING · NA
-
Persona MC vs PS RCT With ROSA
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI